| | | | | | | |
 | GILEAD SCIENCES, INC. | -1.03% | 4.56% | -10.01% | -9.20% | 1.92% | 82 747 |
| VERTEX PHARMACEUTICALS | -1.55% | 1.40% | 34.15% | 51.25% | 57.46% | 76 740 |
| REGENERON PHARMACEUTICALS, INC. | -0.93% | -0.80% | -0.17% | -0.81% | 111.28% | 68 030 |
 | WUXI APPTEC CO., LTD. | -1.25% | -4.17% | -23.44% | -30.13% | 112.14% | 39 407 |
| BIONTECH SE | -2.43% | -5.52% | -42.46% | -59.25% | --.--% | 36 949 |
 | GENMAB A/S | -2.11% | 2.83% | -1.14% | -12.75% | 89.37% | 23 720 |
 | ARGENX SE | -0.53% | 5.13% | 18.90% | 39.68% | 199.68% | 21 105 |
| BEIGENE, LTD. | -1.58% | -6.04% | -34.68% | -38.96% | 19.35% | 18 606 |
| NEUROCRINE BIOSCIENCES, INC. | 0.92% | -1.73% | 24.35% | 15.37% | 7.28% | 10 036 |
| SAREPTA THERAPEUTICS, INC. | -0.27% | -3.60% | 20.72% | 44.95% | -9.64% | 9 545 |
| KARUNA THERAPEUTICS, INC. | 0.86% | 0.90% | 101.12% | 155.72% | 1,141.03% | 8 736 |
| LEGEND BIOTECH CORPORATION | -0.56% | -7.94% | -3.99% | 17.30% | --.--% | 7 329 |
| EXELIXIS, INC. | -0.93% | -0.97% | 4.65% | 4.76% | -15.54% | 6 215 |
| HALOZYME THERAPEUTICS, INC. | -2.33% | -1.56% | 5.45% | 7.29% | 154.20% | 5 981 |
| ASCENDIS PHARMA A/S | -2.26% | 1.73% | -29.68% | -20.88% | -18.23% | 5 402 |
| | | | | | | |
| | Media | -1.07% | -1.05% | 4.25% | 10.96% | 142.33% | |
| | Media ponderata per Capi. | -1.23% | 0.04% | 0.50% | 3.76% | 90.17% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
